Overexpression of KIT in chromophobe renal cell carcinoma

被引:130
作者
Yamazaki, K
Sakamoto, M
Ohta, T
Kanai, Y
Ohki, M
Hirohashi, S
机构
[1] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1600016, Japan
[2] Natl Canc Ctr, Res Inst, Canc Genom Div, Chuou Ku, Tokyo 1040045, Japan
[3] Org Pharmaceut Safety & Res, Chiyoda Ku, Tokyo 1000013, Japan
[4] Natl Canc Ctr, Res Inst, Div Pathol, Chuou Ku, Tokyo 1040045, Japan
关键词
gene-expression profiling; KIT; renal cell carcinoma;
D O I
10.1038/sj.onc.1206153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We analysed gene-expression profiles in 15 surgical specimens of conventional, papillary, and chromophobe renal cell carcinomas (RCCs) using high-density oligonucleotide arrays. From about 12 000 genes targeted by the array, 67 were upregulated specifically in each histological type of RCC. The oncogene KIT was one of the genes whose expression was upregulated specifically in chromophobe RCCs. Immunohistochemical analysis demonstrated the KIT gene product on the cell membrane of chromophobe RCC in all cases, although it was not detected in conventional RCCs or non-neoplastic kidneys except for weak staining in the cytoplasm of renal tubules. These results suggest that each histological subtype of RCC has a unique gene-expression profile, and in particular indicates for the first time that KIT could be a useful marker for chromophobe RCC. As overexpression of KIT might be involved in tumor growth, KIT could be a new therapeutic target in this special type of RCC.
引用
收藏
页码:847 / 852
页数:6
相关论文
共 34 条
[1]   Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirement [J].
Caruana, G ;
Cambareri, AC ;
Gonda, TJ ;
Ashman, LK .
ONCOGENE, 1998, 16 (02) :179-190
[2]   Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].
Cockman, ME ;
Masson, N ;
Mole, DR ;
Jaakkola, P ;
Chang, GW ;
Clifford, SC ;
Maher, ER ;
Pugh, CW ;
Ratcliffe, PJ ;
Maxwell, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741
[3]  
Dijkhuizen T, 1996, INT J CANCER, V68, P47, DOI 10.1002/(SICI)1097-0215(19960927)68:1<47::AID-IJC9>3.0.CO
[4]  
2-X
[5]  
FREEMAN MR, 1989, CANCER RES, V49, P6221
[6]   IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT [J].
FURITSU, T ;
TSUJIMURA, T ;
TONO, T ;
IKEDA, H ;
KITAYAMA, H ;
KOSHIMIZU, U ;
SUGAHARA, H ;
BUTTERFIELD, JH ;
ASHMAN, LK ;
KANAYAMA, Y ;
MATSUZAWA, Y ;
KITAMURA, Y ;
KANAKURA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1736-1744
[7]  
GNERRA JR, 1994, NAT GENET, V7, P85
[8]  
HIBI K, 1991, ONCOGENE, V6, P2291
[9]   Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J].
Hirota, S ;
Isozaki, K ;
Moriyama, Y ;
Hashimoto, K ;
Nishida, T ;
Ishiguro, S ;
Kawano, K ;
Hanada, M ;
Kurata, A ;
Takeda, M ;
Tunio, GM ;
Matsuzawa, Y ;
Kanakura, Y ;
Shinomura, Y ;
Kitamura, Y .
SCIENCE, 1998, 279 (5350) :577-580
[10]   AMPLIFICATION AND OVEREXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR GENE IN HUMAN RENAL-CELL CARCINOMA [J].
ISHIKAWA, J ;
MAEDA, S ;
UMEZU, K ;
SUGIYAMA, T ;
KAMIDONO, S .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (06) :1018-1021